Missteps in "tango" for epigenome targeting

Keith D Robertson, Kapil N. Bhalla

1 Scopus citations

Abstract

In this issue of Blood, Fandy and colleagues describe the results of a trial in which leukemia patients were treated with 5-azacytidine (5-azaC) and the HDAC inhibitor, entinostat. 1 Their results confirm the therapeutic efficacy of these agents but also demonstrate that we have much to learn about the mechanism of action of agents that target the epigenome.

Original languageEnglish (US)
Pages (from-to)2569-2570
Number of pages2
JournalBlood
Volume114
Issue number13
DOIs
StatePublished - 2009
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this